Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk TransCode Therapeutics, Inc. per 2025 Jun 30 adalah -14.65 MM.
- Nilai net income untuk TransCode Therapeutics, Inc. per 2025 Jun 30 adalah -24.60 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -14.65 | -24.60 | |
2025-03-31 | -15.54 | -25.51 | |
2024-12-31 | -15.66 | -16.75 | |
2024-09-30 | -14.67 | -14.93 | |
2024-06-30 | -17.81 | -17.91 | |
2024-03-31 | -17.82 | -17.06 | |
2023-12-31 | -19.42 | -18.55 | |
2023-09-30 | -20.82 | -19.59 | |
2023-06-30 | -20.46 | -18.58 | |
2023-03-31 | -20.04 | -18.91 | |
2022-12-31 | -18.63 | -17.56 | |
2022-09-30 | -16.12 | -15.23 | |
2022-06-30 | -13.53 | -13.27 | |
2022-03-31 | -9.18 | -5.83 | |
2021-12-31 | -6.15 | -6.84 | |
2021-09-30 | -3.54 | -4.85 | |
2021-06-30 | -1.42 | -3.89 | |
2021-03-31 | -1.16 | -6.79 | |
2020-12-31 | -0.73 | -2.34 | |
2020-09-30 | -0.50 | -1.74 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -71.81 | -71.81 |
2024-06-30 | -183.78 | -183.78 |
2024-03-31 | -385.52 | -385.52 |
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk TransCode Therapeutics, Inc. per 2025 Jun 30 adalah -14.35 MM.
- Nilai cash from investing activities untuk TransCode Therapeutics, Inc. per 2025 Jun 30 adalah -0.01 MM.
- Nilai kas dari aktivitas pendanaan untuk TransCode Therapeutics, Inc. per 2025 Jun 30 adalah 18.38 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -14.35 | -0.01 | 18.38 |
2025-03-31 | -12.50 | -0.02 | 19.17 |
2024-12-31 | -13.34 | -0.02 | 16.40 |
2024-09-30 | -15.85 | -0.02 | 10.30 |
2024-06-30 | -15.45 | -0.01 | 15.24 |
2024-03-31 | -17.50 | -0.03 | 20.82 |
2023-12-31 | -18.07 | -0.04 | 15.91 |
2023-09-30 | -16.43 | -0.06 | 15.16 |
2023-06-30 | -17.35 | -0.06 | 7.54 |
2023-03-31 | -16.33 | -0.08 | 1.18 |
2022-12-31 | -15.76 | -0.10 | 0.01 |
2022-09-30 | -13.34 | -0.16 | -0.21 |
2022-06-30 | -11.99 | -0.23 | 25.58 |
2022-03-31 | -8.69 | -0.21 | 25.65 |
2021-12-31 | -5.27 | -0.25 | 25.52 |
2021-09-30 | -3.92 | -0.17 | 25.49 |
2021-06-30 | -0.98 | -0.10 | -0.13 |
2021-03-31 | -1.00 | -0.08 | -0.02 |
2020-12-31 | -0.49 | 1.12 | |
2020-09-30 | -0.37 | 1.33 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah -0.25.
- p/libro untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah 0.63.
- p/tbv untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah 0.63.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.25 | 0.63 | 0.63 |
2025-03-31 | -0.77 | 6.92 | 6.92 |
2024-12-31 | 1.19 | 1.19 | |
2024-09-30 | -0.62 | 8.41 | 8.41 |
2024-06-30 | -0.39 | 1.46 | 1.46 |
2024-03-31 | 1.00 | 1.00 | |
2023-12-31 | -0.21 | 0.95 | 0.95 |
2023-09-30 | -0.06 | 0.49 | 0.49 |
2023-06-30 | -2.02 | -161.72 | -161.72 |
2023-03-31 | -0.35 | 0.65 | |
2022-12-31 | 1.03 | 1.03 | |
2022-09-30 | 1.22 | 1.22 | |
2022-06-30 | -2.76 | 0.95 | 0.95 |
2022-03-31 | -7.69 | 1.61 | 1.61 |
2021-12-31 | -6.75 | 1.41 | 1.41 |
2021-09-30 | -9.92 | -7.66 | -7.66 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah 5.04.
- EBIT (3 tahun) / EV untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah 4.08.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 5.04 | 4.08 |
2025-03-31 | -1.56 | -1.77 |
2024-12-31 | -163.36 | -186.18 |
2024-09-30 | -2.30 | -2.26 |
2024-06-30 | -9.61 | -7.85 |
2024-03-31 | 6.55 | 4.90 |
2023-12-31 | 6.03 | 4.07 |
2023-09-30 | 7.29 | 4.67 |
2023-06-30 | -0.52 | -0.33 |
2023-03-31 | 4.43 | 2.70 |
2022-12-31 | 57.58 | 27.49 |
2022-09-30 | -7.60 | -3.79 |
2022-06-30 | 7.66 | 4.52 |
2022-03-31 | -0.33 | -0.28 |
2021-12-31 | -0.39 | -0.21 |
2021-09-30 | -0.10 | -0.05 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah -5.29.
- roe untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah -19.30.
- roic untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah -2.47.
- croic untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah 0.64.
- ocroic untuk TransCode Therapeutics, Inc. pada 2025 Jun 30 adalah -1.21.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -5.29 | -19.30 | -2.47 | 0.64 | -1.21 |
2025-03-31 | -2.05 | -3.26 | -8.27 | -3.09 | -8.78 |
2024-12-31 | -2.89 | -9.10 | -8.27 | -3.09 | -8.78 |
2024-09-30 | -1.75 | -4.03 | -11.56 | -0.14 | -9.97 |
2024-06-30 | -3.05 | -3.44 | 0.66 | -3.53 | |
2024-03-31 | -2.58 | -6.05 | -3.89 | -0.27 | -3.26 |
2023-12-31 | -1.63 | -2.38 | -3.89 | -0.27 | -3.26 |
2023-09-30 | -1.31 | -1.50 | -6.74 | -3.58 | -6.29 |
2023-06-30 | -1.34 | -1.52 | -6.74 | -3.58 | -6.29 |
2023-03-31 | -0.81 | -0.90 | -35.59 | -28.66 | -30.72 |
2022-12-31 | -0.60 | -0.66 | -1.85 | -1.66 | -1.62 |
2022-09-30 | -0.52 | -0.57 | -1.85 | -1.66 | -1.62 |
2022-06-30 | -3.83 | -1.07 | 1.07 | -0.96 | |
2022-03-31 | -4.67 | -0.34 | 0.99 | -0.51 | |
2021-12-31 | -4.59 | -0.30 | 0.89 | -0.16 | |
2021-09-30 | -3.32 | -0.19 | |||
2021-06-30 | -19.02 | ||||
2021-03-31 | -33.20 | ||||
2020-12-31 | -11.46 | ||||
2020-09-30 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1829635 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |